Hypoalbuminaemia after prolonged treatment with recombinant granulocyte macrophage colony stimulating factor.
- 8 December 1990
- Vol. 301 (6764) , 1312-1313
- https://doi.org/10.1136/bmj.301.6764.1312-a
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- RECOMBINANT HUMAN GRANULOCYTE MACROPHAGE COLONY-STIMULATING FACTOR ENHANCES MONOCYTE CYTO-TOXICITY AND SECRETION OF TUMOR NECROSIS FACTOR-ALPHA AND INTERFERON IN CANCER-PATIENTS1989
- Recombinant human granulocyte/macrophage colony-stimulating factor enhances monocyte cytotoxicity and secretion of tumor necrosis factor alpha and interferon in cancer patientsBlood, 1989
- PRODUCTION OF INTERLEUKIN-1-ALPHA, INTERLEUKIN-1-BETA AND TUMOR NECROSIS FACTOR BY HUMAN MONONUCLEAR-CELLS STIMULATED WITH GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR1988
- Production of interleukin-1 alpha, interleukin-1 beta and tumor necrosis factor by human mononuclear cells stimulated with granulocyte- macrophage colony-stimulating factor [see comments]Blood, 1988
- Effect of Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor on Chemotherapy-Induced MyelosuppressionNew England Journal of Medicine, 1988
- Effect of Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor on Hematopoietic Reconstitution after High-Dose Chemotherapy and Autologous Bone Marrow TransplantationNew England Journal of Medicine, 1988
- Transgenic mice expressing a hemopoietic growth factor gene (GM-CSF) develop accumulations of macrophages, blindness, and a fatal syndrome of tissue damageCell, 1987